2020
DOI: 10.3389/fonc.2020.491129
|View full text |Cite
|
Sign up to set email alerts
|

ADNP Upregulation Promotes Bladder Cancer Cell Proliferation via the AKT Pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 43 publications
2
10
0
Order By: Relevance
“…Transcriptional assessment of ADNP levels in a large cohort of bladder cancer specimens highlighted a significant overexpression in the patients with tumor progression and the association of higher ADNP protein levels to poor prognosis in such patients [ 161 ]. In bladder cancer, ADNP promotes tumor cell growth and proliferation by enhancing the AKT-MDM2-p53 molecular axis which stabilizes cyclin D1 and ultimately leads to cell cycle acceleration from G1 phase to S phase [ 162 ]. In another study, ADNP was found to promote bladder cancer cell migration via TGF- β -mediated epithelial-mesenchymal transition (EMT) pathway [ 161 ].…”
Section: Adnp Dysregulation In Cancer Developmentmentioning
confidence: 99%
“…Transcriptional assessment of ADNP levels in a large cohort of bladder cancer specimens highlighted a significant overexpression in the patients with tumor progression and the association of higher ADNP protein levels to poor prognosis in such patients [ 161 ]. In bladder cancer, ADNP promotes tumor cell growth and proliferation by enhancing the AKT-MDM2-p53 molecular axis which stabilizes cyclin D1 and ultimately leads to cell cycle acceleration from G1 phase to S phase [ 162 ]. In another study, ADNP was found to promote bladder cancer cell migration via TGF- β -mediated epithelial-mesenchymal transition (EMT) pathway [ 161 ].…”
Section: Adnp Dysregulation In Cancer Developmentmentioning
confidence: 99%
“…At a molecular level, ADNP was found to activate the AKT/ MDM2 / p53 signaling pathway, thus promoting bladder cancer cell proliferation. Taken together, ADNP is overexpressed in bladder cancer and may act as an oncogene in bladder tumorigenesis [ 137 ]. Hence, ADNP may be a novel molecular target for predicting prognosis in bladder cancer as well as adjuvant therapeutic for bladder cancer patients receiving intravesical chemotherapy.…”
Section: Homeobox Genes In Bladder Cancermentioning
confidence: 99%
“…However, the activation of ADNP signaling system, mediated by an endogenous pituitary adenylate cyclase-activating polypeptide, can increase the resistance of malignant peripheral nerve sheath tumor to H2O2-induced death with serum starvation [16]. Our previous study has shown that overexpression of ADNP in BC stimulated the Akt-MDM2-p53 pathway and enhanced binding of cyclin D1 to CDK4 or CDK6, accelerating the cell cycle transition from G1 phase to S phase [17]. ADNP may act as an oncogene in certain cellular contexts.…”
Section: Ivyspringmentioning
confidence: 99%